Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes.

Autor: Mitroulis I; Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece.; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany., Papadopoulos V; Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece., Lamprianidou E; Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece., Mirtschink P; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Dresden, Germany., Liapis K; Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece., Zafeiropoulou K; Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece., Kourakli A; Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece., Moysiadis T; Department of Computer Science, School of Sciences and Engineering, University of Nicosia, Nicosia, 2417, Cyprus., Papoutselis M; Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece., Vrachiolias G; Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece., Symeonidis A; Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece., Kotsianidis I; Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece. ikotsian@med.duth.gr.
Jazyk: angličtina
Zdroj: Blood cancer journal [Blood Cancer J] 2023 May 03; Vol. 13 (1), pp. 64. Date of Electronic Publication: 2023 May 03.
DOI: 10.1038/s41408-023-00844-4
Databáze: MEDLINE